Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lee E. Sheinkopf
Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Utility of Impulse Oscillometry in Patients With Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria
Pediatrics
Child Health
Pediatrics
Perinatology
Effect of Omalizumab on Lung Function and Eosinophil Levels in Adolescents With Moderate-To-Severe Allergic Asthma
Annals of Allergy, Asthma and Immunology
Respiratory Medicine
Pulmonary
Allergy
Immunology
Omalizumab Treatment in Brittle Asthma
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
First Experience With Omalizumab in a Child With Severe Persistent Asthma in Turkey: Case Report
Turkiye Klinikleri Journal of Medical Sciences
Medicine
Prs10 - Population Health Impact of Omalizumab Over 11 Years of Use in Ireland in Moderate to Severe Allergic Asthma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental